
Sign up to save your podcasts
Or


In this episode, Nick Chmielewski speaks with David Wildebrandt, a partner and managing director at BRG. They discuss key findings from BRG's recent 2025 US Healthcare & Life Sciences Transactions Outlook report, including transactional evolution and industry disruptors.
By BRG5
88 ratings
In this episode, Nick Chmielewski speaks with David Wildebrandt, a partner and managing director at BRG. They discuss key findings from BRG's recent 2025 US Healthcare & Life Sciences Transactions Outlook report, including transactional evolution and industry disruptors.

91,149 Listeners

1,459 Listeners

1,033 Listeners

112,342 Listeners

56,375 Listeners

5,441 Listeners

6,373 Listeners

808 Listeners

31 Listeners

2,095 Listeners

665 Listeners

24 Listeners

7,857 Listeners

20,308 Listeners